AMERISAFE Capex To Revenue from 2010 to 2024

AMSF Stock  USD 53.07  0.26  0.49%   
AMERISAFE's Capex To Revenue is decreasing over the last several years with slightly volatile swings. Capex To Revenue is predicted to flatten to 0. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.00180183
Current Value
0.001712
Quarterly Volatility
0.01036841
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AMERISAFE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AMERISAFE's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 0.0 or Selling General Administrative of 24.1 M, as well as many indicators such as Price To Sales Ratio of 1.46, Dividend Yield of 0.1 or PTB Ratio of 3.22. AMERISAFE financial statements analysis is a perfect complement when working with AMERISAFE Valuation or Volatility modules.
  
Check out the analysis of AMERISAFE Correlation against competitors.
For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.

Latest AMERISAFE's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of AMERISAFE over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. AMERISAFE's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AMERISAFE's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

AMERISAFE Capex To Revenue Regression Statistics

Arithmetic Mean0.01
Geometric Mean0
Coefficient Of Variation178.22
Mean Deviation0.01
Median0
Standard Deviation0.01
Sample Variance0.0001
Range0.0417
R-Value(0.43)
Mean Square Error0.000094
R-Squared0.19
Significance0.11
Slope(0)
Total Sum of Squares0

AMERISAFE Capex To Revenue History

2024 0.001712
2023 0.001802
2022 0.007089
2021 0.004101
2020 0.002713
2019 0.002749
2018 0.002981

About AMERISAFE Financial Statements

AMERISAFE stakeholders use historical fundamental indicators, such as AMERISAFE's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although AMERISAFE investors may analyze each financial statement separately, they are all interrelated. For example, changes in AMERISAFE's assets and liabilities are reflected in the revenues and expenses on AMERISAFE's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AMERISAFE. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Currently Active Assets on Macroaxis

When determining whether AMERISAFE is a strong investment it is important to analyze AMERISAFE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AMERISAFE's future performance. For an informed investment choice regarding AMERISAFE Stock, refer to the following important reports:
Check out the analysis of AMERISAFE Correlation against competitors.
For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMERISAFE. If investors know AMERISAFE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMERISAFE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.443
Dividend Share
1.45
Earnings Share
3.21
Revenue Per Share
16.5
Quarterly Revenue Growth
0.083
The market value of AMERISAFE is measured differently than its book value, which is the value of AMERISAFE that is recorded on the company's balance sheet. Investors also form their own opinion of AMERISAFE's value that differs from its market value or its book value, called intrinsic value, which is AMERISAFE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMERISAFE's market value can be influenced by many factors that don't directly affect AMERISAFE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMERISAFE's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMERISAFE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMERISAFE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.